CAS # 100286-90-6
USP / EP Injectable Grade (MW 623.1 g/mol)
Irinotecan / Irinotecan HCl Topoisomerase I Inhibitor
Irinotecan Hydrochloride is a camptothecin-derived prodrug converted to active metabolite SN-38. Core component in first-line and refractory metastatic colorectal cancer chemotherapy (FOLFIRI).
Assay / Purity
98.0% - 102.0% (C33H39ClN4O6)
Physical Appearance
Pale Yellow Crystalline Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Irinotecan / Irinotecan HCl Topoisomerase I Inhibitor
CAS Registry Number
100286-90-6
Standard Grade
USP / EP Injectable Grade (MW 623.1 g/mol)
Assay / Purity
98.0% - 102.0% (C33H39ClN4O6)
Appearance
Pale Yellow Crystalline Powder
Formulation & Industry Applications
Colorectal Cancer Infusions
FOLFIRI Chemotherapy Regimens
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: